Lexington Partners’s Medline MDLN Stock Holding History
Bought
Maintained
Sold
Other funds holding MDLN
Lexington Partners's MDLN Position: Q2 2026 in Review
Lexington Partners sold out of Medline (MDLN) in Q2 2026, closing a stake of 134,232 shares — an estimated $5.97M sold.
Lexington Partners first reported a position in MDLN in Q4 2025 and held it in 2 quarters. The position peaked at $5.97M in Q1 2026. 413 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.
- Lexington Partners reported no remaining Medline position as of Q2 2026 after selling out during the quarter.
- Lexington Partners sold 134,232 Medline shares in Q2 2026, an estimated $5.97M.
- Lexington Partners first reported a position in Medline in Q4 2025 and held it in 2 quarters.
- Lexington Partners's Medline position peaked at $5.97M in Q1 2026.
- 413 funds tracked by Wall St. Rank held Medline as of Q2 2026.
Based on Lexington Partners's 13F filing for Q2 2026, filed 7 Aug 2026.